| Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: potential therapeutic targets in ischemic heart disease A Al-Darraji, D Haydar, L Chelvarajan, H Tripathi, B Levitan, E Gao, ... PloS one 13 (7), e0200474, 2018 | 51 | 2018 |
| Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction H Tripathi, A Al-Darraji, M Abo-Aly, H Peng, E Shokri, L Chelvarajan, ... Journal of molecular and cellular cardiology 149, 95-114, 2020 | 22 | 2020 |
| Gelatin based polymer cell coating improves bone marrow-derived cell retention in the heart after myocardial infarction A Gottipati, L Chelvarajan, H Peng, R Kong, CF Cahall, C Li, H Tripathi, ... Stem cell reviews and reports 15, 404-414, 2019 | 20 | 2019 |
| Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction A Al-Darraji, RR Donahue, H Tripathi, H Peng, BM Levitan, L Chelvarajan, ... Scientific reports 10 (1), 16596, 2020 | 15 | 2020 |
| Isolation methods for human CD34 subsets using fluorescent and magnetic activated cell sorting: an in vivo comparative study H Tripathi, H Peng, R Donahue, L Chelvarajan, A Gottipati, B Levitan, ... Stem cell reviews and reports 16, 413-423, 2020 | 15 | 2020 |
| Polymer cell surface coating enhances mesenchymal stem cell retention and cardiac protection H Peng, L Chelvarajan, R Donahue, A Gottipati, CF Cahall, KA Davis, ... ACS Applied Bio Materials 4 (2), 1655-1667, 2021 | 12 | 2021 |
| C-reactive protein levels and risk of cardiovascular diseases: a two-sample bidirectional Mendelian randomization study A Kuppa, H Tripathi, A Al-Darraji, WM Tarhuni, A Abdel-Latif International Journal of Molecular Sciences 24 (11), 9129, 2023 | 8 | 2023 |
| Gelatin coating enhances therapeutic cell adhesion to the infarcted myocardium via ECM binding KA Davis, A Gottipatti, H Peng, R Donahue, L Chelvarajan, C Cahall, ... PLoS One 17 (11), e0277561, 2022 | 4 | 2022 |
| Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on pulmonary function in hypertensive patients AS Jabbar, NF Neamah, AH Al-Darraji Journal of Basic and Clinical Physiology and Pharmacology 33 (2), 207-212, 2022 | 3 | 2022 |
| Liposomal Compounds and Methods of Use Thereof VJ Venditto, A Abdel-Latif, A Al-Darraji, D Feola, JC Gensel US Patent App. 18/136,298, 2023 | | 2023 |
| Liposomal compounds and methods of use thereof VJ Venditto, A Abdel-Latif, A Al-Darraji, D Feola, JC Gensel US Patent 11,660,269, 2023 | | 2023 |
| African Journal of Pharmaceutical Sciences AH Al-Darraji | | 2023 |
| A newly synthetic compound of Ibuprofen and Gabapentin as a novel analgesic and anti-inflammatory therapeutic agent: A pharmacological study in rats’ experimental models M Abdulkhaliq Ibrahim, HN Alsaad, AH Al-Darraji, MF Mahdi Journal of Emergency Medicine, Trauma & Acute Care 2021 (3), 24, 2021 | | 2021 |
| Screening of major endocrine disorders among stations of oil products distributions in Basrah city, Iraq. AH AL-DARRAJI, AA Jaccob, YS ABDULAZEEZ, SA AlKadhi Asia Pacific Journal of Medical Toxicology 10 (1), 2021 | | 2021 |
| Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (vol 10, 16596, 2020) A Al-Darraji, RR Donahue, H Tripathi, H Peng, BM Levitan, L Chelvarajan, ... SCIENTIFIC REPORTS 11 (1), 2021 | | 2021 |
| Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction A Al‑Darraji, RR Donahue, H Tripathi, H Peng, BM Levitan, L Chelvarajan, ... Scientific Reports 11 (1), 6654, 2021 | | 2021 |
| Role of Lipid Phosphate Phosphatase3 in Cardiac Inflammation H Tripathi, A Al-Darraji, E Gao, L Chelvarajan, B Levitan, AJ Morris, ... Circulation 138 (Suppl_1), A14640-A14640, 2018 | | 2018 |
| Autotaxin Inhibition Reduces Cardiac Inflammation and Mitigates Adverse Cardiac Remodeling After Myocardial Infarction: Potential Therapeutic Targets for Ischemic Heart Disease H Tripathi, L Chelvarajan, A Al-Darraji, S Ye, B Levitan, JA Brandon, ... Circulation 136 (suppl_1), A17988-A17988, 2017 | | 2017 |
| Azithromycin Therapy Reduces Cardiac Inflammation and Mitigates Adverse Cardiac Remodeling After Myocardial Infarction: Potential Therapeutic Strategy in Ischemic Heart Disease A Al-Darraji, D Haydar, L Chelvarajan, H Tripathi, B Levitan, AE Ahmed, ... Circulation 136 (suppl_1), A17896-A17896, 2017 | | 2017 |
